FDA Inspection 1277670 — Accupack Midwest Inc

Accupack Midwest Inc — FEI 1000122754

The FDA completed an inspection of Accupack Midwest Inc on July 23, 2025 in Cincinnati, OH. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 23, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cincinnati, OH (United States)